{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:56:40Z","timestamp":1790845000567,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ad.2026.104687","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:18:45Z","timestamp":1778944725000},"page":"104687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Androgenetic Alopecia: Narrative Review of Current Therapies and Proposal of a Practical Algorithm for Pharmacological Treatment"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3371-7676","authenticated-orcid":false,"given":"A.","family":"G\u00f3mez Zubiaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Va\u00f1\u00f3-Galv\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Garnacho-Saucedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2026.104687_bib0410","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jdv.14624","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men: short version","volume":"32","author":"Kanti","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2026.104687_bib0415","first-page":"457","article-title":"A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women","volume":"17","author":"Lee","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263912","article-title":"Epidemiology and disease burden of androgenetic alopecia in college freshmen in China: a population-based study","volume":"17","author":"He","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ad.2026.104687_bib0425","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/cen.14710","article-title":"Approach to androgen excess in women: clinical and biochemical insights","volume":"97","author":"Cussen","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ad.2026.104687_bib0430","series-title":"Endotext.","article-title":"Male androgenetic alopecia","author":"Cranwell","year":"2016"},{"key":"10.1016\/j.ad.2026.104687_bib0435","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijwd.2018.05.001","article-title":"Female pattern hair loss: a clinical, pathophysiologic, and therapeutic review","volume":"4","author":"Fabbrocini","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0440","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jocd.14983","article-title":"The psychological consequences of androgenetic alopecia: a systematic review","volume":"22","author":"Aukerman","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0445","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/exd.13373","article-title":"Genetics and other factors in the aetiology of female pattern hair loss","volume":"26","author":"Redler","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0450","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1365-2133.2010.09661.x","article-title":"Female pattern hair loss in complete androgen insensitivity syndrome","volume":"162","author":"Cousen","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0455","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1111\/jocd.14537","article-title":"Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics","volume":"20","author":"Nestor","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0460","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s00105-013-2579-0","article-title":"Androgenetic alopecia: diagnosis and therapy \u2013 a current review","volume":"64","author":"Blume-Peytavi","year":"2013","journal-title":"Hautarzt"},{"key":"10.1016\/j.ad.2026.104687_bib0465","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40257-019-00493-z","article-title":"Topical antiandrogen therapies for androgenetic alopecia and acne vulgaris","volume":"21","author":"Marks","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12703\/r\/11-1","article-title":"Advances in hair growth","volume":"11","author":"Wall","year":"2022","journal-title":"Fac Rev"},{"key":"10.1016\/j.ad.2026.104687_bib0475","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40265-023-01880-x","article-title":"Androgenetic alopecia: therapy update","volume":"83","author":"Devjani","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.ad.2026.104687_bib0480","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2147\/CCID.S385861","article-title":"Treatment of androgenetic alopecia: current guidance and unmet needs","volume":"16","author":"Kaiser","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0485","series-title":"StatPearls","article-title":"Minoxidil","author":"Patel","year":"2023"},{"key":"10.1016\/j.ad.2026.104687_bib0490","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/ced.15338","article-title":"Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit?","volume":"47","author":"Singh","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0495","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/jocd.15953","article-title":"Efficacy of the association of topical minoxidil and topical finasteride vs their use in monotherapy in men with androgenetic alopecia: a prospective, randomized, controlled, assessor-blinded, 3-arm pilot trial","volume":"23","author":"Rossi","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0500","article-title":"Comparing current therapeutic modalities of androgenic alopecia: a literature review of clinical trials","volume":"15","author":"Bajoria","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ad.2026.104687_bib0505","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/09546639709160517","article-title":"Topical finasteride in the treatment of androgenic alopecia: preliminary evaluations after a 16-month therapy course","volume":"8","author":"Mazzarella","year":"1997","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2026.104687_bib0510","doi-asserted-by":"crossref","first-page":"842","DOI":"10.5414\/CP202119","article-title":"A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers","volume":"52","author":"Caserini","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ad.2026.104687_bib0515","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5414\/CP202467","article-title":"Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia","volume":"54","author":"Caserini","year":"2016","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ad.2026.104687_bib0520","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jdv.17738","article-title":"Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial","volume":"36","author":"Piraccini","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2026.104687_bib0525","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/jps.24045","article-title":"Topical formulations containing finasteride. Part II: determination of finasteride penetration into hair follicles using the differential stripping technique","volume":"103","author":"Tampucci","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ad.2026.104687_bib0530","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/09546634.2020.1782324","article-title":"Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature","volume":"33","author":"Suchonwanit","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2026.104687_bib0535","first-page":"1017","article-title":"Topical finasteride versus topical spironolactone in the treatment of androgenetic alopecia","volume":"88","author":"Ahmed","year":"2020","journal-title":"Med J Cairo Univ"},{"key":"10.1016\/j.ad.2026.104687_bib0540","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13202","article-title":"Topical ketoconazole for the treatment of androgenetic alopecia: a systematic review","volume":"33","author":"Fields","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2026.104687_bib0545","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaad.2011.05.026","article-title":"A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment with latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia","volume":"66","author":"Blume-Peytavi","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0550","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41598-022-05544-w","article-title":"Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia","volume":"12","author":"Yun","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ad.2026.104687_bib0555","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). CIMA [Internet]. Ficha t\u00e9cnica de finasterida oral 1mg. https:\/\/cima.aemps.es\/cima\/pdfs\/ft\/76704\/FT_76704.pdf. Accessed 2025."},{"key":"10.1016\/j.ad.2026.104687_bib0560","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1529-8019.2011.01441.x","article-title":"Finasteride, 1mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up","volume":"24","author":"Rossi","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2026.104687_bib0565","first-page":"400","article-title":"Long-term treatment with finasteride 1mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss)","volume":"18","author":"Kaufman","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0570","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archdermatol.2010.256","article-title":"Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review","volume":"146","author":"Mella","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0575","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/1346-8138.14719","article-title":"Evaluation of longterm efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system","volume":"46","author":"Shin","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0580","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/1346-8138.12890","article-title":"Five-year efficacy of finasteride in 801 Japanese men with androgenetic alopecia","volume":"42","author":"Yoshitake","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0585","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jocd.15910","article-title":"The relative effect of monotherapy with 5-alpha reductase inhibitors and minoxidil for female pattern hair loss: a network meta-analysis study","volume":"23","author":"Gupta","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0590","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/ijt.ijt_73_16","article-title":"Mesotherapy with dutasteride in the treatment of androgenetic alopecia","volume":"9","author":"Saceda-Corralo","year":"2017","journal-title":"Int J Trichology"},{"key":"10.1016\/j.ad.2026.104687_bib0595","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/CIA.S192435","article-title":"The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis","volume":"14","author":"Zhou","year":"2019","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.ad.2026.104687_bib0815","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1111\/jocd.16362","article-title":"The impact of monotherapies for male androgenetic alopecia: A network meta-analysis study","volume":"23","author":"Gupta","year":"2024","journal-title":"J Cosmet Dermatol."},{"key":"10.1016\/j.ad.2026.104687_bib0605","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13182","article-title":"Effectiveness and safety of oral dutasteride for male androgenetic alopecia in real clinical practice: a descriptive monocentric study","volume":"33","author":"Vano-Galvan","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2026.104687_bib0610","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4103\/0378-6323.144162","article-title":"The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia","volume":"80","author":"Boersma","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.ad.2026.104687_bib0615","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1111\/jdv.15891","article-title":"Oral minoxidil bio-activation by hair follicle outer root sheath cell sulfotransferase enzymes predicts clinical efficacy in female pattern hair loss","volume":"34","author":"Ramos","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2026.104687_bib0620","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2020.06.1009","article-title":"Oral minoxidil treatment for hair loss: a review of efficacy and safety","volume":"84","author":"Randolph","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0625","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000525137","article-title":"There is a positive dose-dependent association between low-dose oral minoxidil and its efficacy for androgenetic alopecia: findings from a systematic review with meta-regression analyses","volume":"8","author":"Gupta","year":"2022","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.ad.2026.104687_bib0630","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ad.2021.03.003","article-title":"Serious adverse effects from compounding errors with low-dose oral minoxidil for alopecia treatment","volume":"113","author":"Moreno-Arrones","year":"2022","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2026.104687_bib0635","doi-asserted-by":"crossref","first-page":"T407","DOI":"10.1016\/j.ad.2024.02.001","article-title":"Low-dose oral minoxidil severe adverse effects as a consequence of compounding errors","volume":"115","author":"Moreno-Arrones","year":"2024","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2026.104687_bib0640","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jaad.2021.02.054","article-title":"Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients","volume":"84","author":"Vano-Galvan","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0645","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/CCID.S398950","article-title":"The efficacy and safety of oral and topical spironolactone in androgenetic alopecia treatment: a systematic review","volume":"16","author":"Wang","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0650","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaad.2021.07.048","article-title":"Efficacy and safety profile of oral spironolactone use for androgenic alopecia: a systematic review","volume":"86","author":"James","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0655","doi-asserted-by":"crossref","first-page":"e14678","DOI":"10.1111\/dth.14678","article-title":"A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: clinical, histopathological, and physicochemical study","volume":"34","author":"Abdel-Raouf","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2026.104687_bib0660","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamadermatol.2021.5866","article-title":"Association of spironolactone use with risk of cancer: a systematic review and metaanalysis","volume":"158","author":"Bommareddy","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0665","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ad.2023.10.043","article-title":"Recommendations on the clinical management of androgenetic alopecia: a consensus statement from the Spanish Trichology Group of the Spanish Academy of Dermatology and Venererology (AEDV)","volume":"115","author":"Vano-Galvan","year":"2024","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2026.104687_bib0670","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jaad.2020.03.034","article-title":"Safety of oral bicalutamide in female pattern hair loss: a retrospective review of 316 patients","volume":"83","author":"Ismail","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0675","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/j.jaad.2020.04.054","article-title":"Bicalutamide: a potential new oral antiandrogenic drug for female pattern hair loss","volume":"83","author":"Fernandez-Nieto","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0680","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijwd.2017.01.001","article-title":"Hormonal therapy in female pattern hair loss","volume":"3","author":"Brough","year":"2017","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0685","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.abd.2022.09.006","article-title":"Female pattern hair loss: therapeutic update","volume":"98","author":"Muller Ramos","year":"2023","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0695","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10103-019-02723-6","article-title":"Comparative effectiveness of low-level laser therapy for adult androgenic alopecia: a system review and meta-analysis of randomized controlled trials","volume":"34","author":"Liu","year":"2019","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.ad.2026.104687_bib0700","first-page":"E64","article-title":"A systematic review and meta-analysis of randomized controlled trials of United States Food and Drug Administration-approved, home-use low-level light\/laser therapy devices for pattern hair loss: device design and technology","volume":"14","author":"Lueangarun","year":"2021","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0705","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1007\/s10103-022-03520-4","article-title":"Efficacy assessment for low-level laser therapy in the treatment of androgenetic alopecia: a real-world study on 1383 patients","volume":"37","author":"Qiu","year":"2022","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.ad.2026.104687_bib0710","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1524-4725.2010.01833.x","article-title":"Fractional photothermolysis laser treatment of male pattern hair loss","volume":"37","author":"Kim","year":"2011","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ad.2026.104687_bib0715","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1468-3083.2011.04183.x","article-title":"The effect of a 1550nm fractional erbium-glass laser in female pattern hair loss","volume":"25","author":"Lee","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2026.104687_bib0720","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/jocd.16173","article-title":"Investigator-blinded, controlled, and randomized comparative study on 1565nm non-ablative fractional laser versus 5% minoxidil for treatment of androgenetic alopecia","volume":"23","author":"Qu","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0725","first-page":"858","article-title":"Laser-assisted drug delivery","volume":"109","author":"Alegre-Sanchez","year":"2018","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"10.1016\/j.ad.2026.104687_bib0730","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10103-024-04054-7","article-title":"Lasers in the management of alopecia: a review of established therapies and advances in treatment","volume":"39","author":"Jean-Pierre","year":"2024","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.ad.2026.104687_bib0735","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00266-023-03603-9","article-title":"Effectiveness of platelet-rich plasma in the treatment of androgenic alopecia: a meta-analysis","volume":"48","author":"Li","year":"2024","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.ad.2026.104687_bib0740","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s00266-019-01391-9","article-title":"Platelet-rich plasma for treating androgenic alopecia: a systematic review","volume":"43","author":"Mao","year":"2019","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.ad.2026.104687_bib0745","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00266-023-03482-0","article-title":"Platelet-rich plasma for treating androgenic alopecia: a systematic review","volume":"48","author":"Pensato","year":"2024","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.ad.2026.104687_bib0750","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/12034754231191461","article-title":"Platelet-rich plasma for androgenetic alopecia: a systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Zhang","year":"2023","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.ad.2026.104687_bib0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ijt.ijt_50_19","article-title":"Combination therapy with platelet-rich plasma and minoxidil leads to better clinical results than monotherapy with these methods in men with androgenetic alopecia","volume":"14","author":"Elena","year":"2022","journal-title":"Int J Trichology"},{"key":"10.1016\/j.ad.2026.104687_bib0760","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.mjafi.2020.11.010","article-title":"Comparison of 5% minoxidil lotion monotherapy versus its combination with autologous platelet rich plasma in androgenetic alopecia in hundred males","volume":"77","author":"Ray","year":"2021","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.ad.2026.104687_bib0765","doi-asserted-by":"crossref","DOI":"10.1111\/srt.13315","article-title":"Injections of platelet-rich plasma prepared by automatic blood cell separator combined with topical 5% minoxidil in the treatment of male androgenetic alopecia","volume":"29","author":"Wei","year":"2023","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.ad.2026.104687_bib0770","first-page":"137","article-title":"Mesotherapy using dutasteride-containing solution in male pattern hair loss: a controlled pilot study","volume":"20","author":"Abdallah","year":"2009","journal-title":"J Pan Arab Leag Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0775","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7241\/ourd.20131.08","article-title":"Evaluation of the effect of injection of dutasteride as mesotherapeutic tool in treatment of androgenetic alopecia in males","volume":"4","author":"Sobhy","year":"2013","journal-title":"Our Dermatol Online"},{"key":"10.1016\/j.ad.2026.104687_bib0780","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1468-3083.2012.04535.x","article-title":"Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation","volume":"27","author":"Moftah","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2026.104687_bib0785","first-page":"742","article-title":"Mesotherapy with dutasteride for androgenetic alopecia: a retrospective study in real clinical practice","volume":"21","author":"Saceda-Corralo","year":"2022","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0790","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/ijt.ijt_78_21","article-title":"Mesotherapy with bicalutamide: a new treatment for androgenetic alopecia","volume":"15","author":"Gomez-Zubiaur","year":"2023","journal-title":"Int J Trichology"},{"key":"10.1016\/j.ad.2026.104687_bib0795","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jocd.14525","article-title":"Microneedling for hair loss","volume":"21","author":"Gupta","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.ad.2026.104687_bib0820","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ad.2025.01.012","article-title":"Subcutaneous versus combined subcutaneous and intramuscular botulinum toxin for androgenetic alopecia: a randomized clinical trial","volume":"116","author":"Lima-Galindo","year":"2025","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2026.104687_bib0805","unstructured":"ClinicalTrials.gov [internet]. Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029 [accessed May 25, 2026]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05428449."},{"key":"10.1016\/j.ad.2026.104687_bib0810","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.acuro.2019.08.002","article-title":"Review of the experience and evidence of Pygeum africanum in urological practice","volume":"44","author":"Salinas-Casado","year":"2020","journal-title":"Actas Urol Esp (Engl Ed)"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731026000979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731026000979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:07:19Z","timestamp":1790842039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731026000979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":80,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0001731026000979"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2026.104687","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgenetic Alopecia: Narrative Review of Current Therapies and Proposal of a Practical Algorithm for Pharmacological Treatment","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2026.104687","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"104687"}}